" class="no-js "lang="en-US"> Acorda Therapeutics Archives - Medtech Alert
Tuesday, May 28, 2024

Sort by:


Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Acorda Launches INBRIJA® TV Commercial for Parkinson’s Awareness Month

Acorda Therapeutics today announced that it has launched an INBRIJA® (levodopa inhalation powder) television commercial […]

Acorda Therapeutics Announces New Agreement with Catalent for Long-Term Global Supply of INBRIJA®

Acorda Therapeutics has announced that on December 31, 2022 it entered into a new long-term […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more